Press Releases
2008 | 2007 | 2006 | 2005

	Date	2006 Press Releases
	09.21.06	Zelos and Nektar Announce Start of Phase 1 Trial of Inhaled Ostabolin-C™ for Osteoporosis
	07.20.06	Zelos Therapeutics Appoints Colin Goddard, Ph.D. To Board Of Directors
	05.18.06	Jay Mohr and Martin Stogniew Join Zelos Therapeutics to Develop Exciting New Osteoporosis Drug, Ostabolin-C™
	02.09.06	Zelos Therapeutics Completes Enrollment in Two Ostabolin-C™ Phase 2 Clinical Trials

Click here to receive the latest news from Zelos.